Actively Recruiting
Ovarian PRP for Diminished Ovarian Reserve
Led by Generation Next Fertility · Updated on 2025-02-13
230
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
Sponsors
G
Generation Next Fertility
Lead Sponsor
I
Igenomix
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
CONDITIONS
Official Title
Ovarian PRP for Diminished Ovarian Reserve
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of diminished ovarian reserve
- Clinical diagnosis of poor ovarian response
- Women age 35-42
You will not qualify if you...
- Clinical diagnosis of premature ovarian failure
- Clinical diagnosis of menopause
- Under 35 years of age
- Over 42 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Generation Next Fertility
New York, New York, United States, 10022
Actively Recruiting
Research Team
A
Alicia Broussard, PhD
CONTACT
J
Jesse Hade, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here